| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9.1M | +8.1% | -74.7% |
| SG&A Expense | $3.6M | -5.3% | -38.6% |
| Operating Income | -$12.7M | -4.0% | -122.7% |
| Interest Expense | $1.4M | — | +77.1% |
| Net Income | -$11.9M | -4.8% | -188.3% |
| EPS (Basic) | -$0.64 | -4.9% | -1500.0% |
| EPS (Diluted) | -$0.64 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $42.4M | -52.1% | -63.7% |
| Short-term Investments | $34.6M | — | +592.9% |
| Current Assets | $78.2M | -14.7% | -36.2% |
| Total Assets | $81.2M | -12.6% | -33.8% |
| Current Liabilities | $6.1M | -20.7% | +329.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.3M | — | — |
| Capital Expenditures | $183K | — | — |
| Investing Cash Flow | -$34.7M | — | — |
| Financing Cash Flow | $107.3M | — | — |
| Free Cash Flow | -$31.5M | — | — |
| -1500.0% |
| $39.3M |
| -1.0% |
| +2684.0% |
| Stockholders' Equity | $41.9M | -21.2% | -65.4% |